Cardiac epinephrine synthesis and ischemia-induced myocardial epinephrine release. 2007

Yosuke Kuroko, and Toji Yamazaki, and Noriyuki Tokunaga, and Tsuyoshi Akiyama, and Hirotoshi Kitagawa, and Kozo Ishino, and Shunji Sano, and Hidezo Mori
Department of Cardiovascular Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama, 700-8558, Japan.

OBJECTIVE Phenylethanolamine-N-methyltransferase (PNMT), the enzyme that synthesizes epinephrine (EPI) from norepinephrine (NE) in the adrenal gland, is present in extra-adrenal tissues including heart. Ischemia evokes an excessive NE accumulation in the myocardial interstitial spaces. Therefore, cardiac PNMT activity with high NE levels may contribute to cardiac EPI synthesis and release evoked by ischemia. METHODS We measured dialysate EPI levels in the left ventricle of anesthetized rabbits using a cardiac microdialysis technique. The dialysate EPI level served as an index of the myocardial interstitial EPI level. Locally administered NE-induced dialysate EPI responses were measured. The left circumflex coronary artery was occluded for 60 min and the dialysate EPI and NE levels in the ischemic region were measured. Coronary occlusion-induced EPI responses were compared with and without administration of a PNMT inhibitor (SKF29661) in the presence and absence of desipramine (catecholamine transport blocker). RESULTS Local administration of NE (250, 2500 ng/ml) increased the EPI levels to 734+/-125 and 2088+/-367 pg/ml respectively. These increases in dialysate EPI were suppressed by the PNMT inhibitor. Acute myocardial ischemia significantly increased the EPI levels to 3607+/-1069 pg/ml in the ischemic region, and these were suppressed by the PNMT inhibitor (1417+/-581 pg/ml). The pretreatment with desipramine suppressed ischemia-induced EPI release, which did not differ with (725+/-155 pg/ml) and without administration of a PNMT inhibitor (743+/-172 pg/ml). CONCLUSIONS The cardiac PNMT in the left ventricle is capable of synthesizing EPI with markedly elevated NE levels in the myocardial interstitial space.

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D008297 Male Males
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D010625 Phenylethanolamine N-Methyltransferase A methyltransferase that catalyzes the reaction of S-adenosyl-L-methionine and phenylethanolamine to yield S-adenosyl-L-homocysteine and N-methylphenylethanolamine. It can act on various phenylethanolamines and converts norepinephrine into epinephrine. (From Enzyme Nomenclature, 1992) EC 2.1.1.28. Phenethanolamine N-Methyltransferase,Noradrenalin N-Methyltransferase,Noradrenaline N-Methyltransferase,Norepinephrine Methyltransferase,Norepinephrine N-Methyltransferase,Methyltransferase, Norepinephrine,Noradrenalin N Methyltransferase,Noradrenaline N Methyltransferase,Norepinephrine N Methyltransferase,Phenethanolamine N Methyltransferase,Phenylethanolamine N Methyltransferase
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003891 Desipramine A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors. Desmethylimipramine,Apo-Desipramine,Demethylimipramine,Desipramine Hydrochloride,Norpramin,Novo-Desipramine,Nu-Desipramine,PMS-Desipramine,Pertofran,Pertofrane,Pertrofran,Petylyl,Ratio-Desipramine,Apo Desipramine,Hydrochloride, Desipramine,Novo Desipramine,Nu Desipramine,PMS Desipramine,Ratio Desipramine
D003956 Dialysis A process of selective diffusion through a membrane. It is usually used to separate low-molecular-weight solutes which diffuse through the membrane from the colloidal and high-molecular-weight solutes which do not. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Dialyses
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D004837 Epinephrine The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS. Adrenaline,4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol,Adrenaline Acid Tartrate,Adrenaline Bitartrate,Adrenaline Hydrochloride,Epifrin,Epinephrine Acetate,Epinephrine Bitartrate,Epinephrine Hydrochloride,Epinephrine Hydrogen Tartrate,Epitrate,Lyophrin,Medihaler-Epi,Acetate, Epinephrine

Related Publications

Yosuke Kuroko, and Toji Yamazaki, and Noriyuki Tokunaga, and Tsuyoshi Akiyama, and Hirotoshi Kitagawa, and Kozo Ishino, and Shunji Sano, and Hidezo Mori
January 1988, Psychosomatic medicine,
Yosuke Kuroko, and Toji Yamazaki, and Noriyuki Tokunaga, and Tsuyoshi Akiyama, and Hirotoshi Kitagawa, and Kozo Ishino, and Shunji Sano, and Hidezo Mori
September 1990, Circulation,
Yosuke Kuroko, and Toji Yamazaki, and Noriyuki Tokunaga, and Tsuyoshi Akiyama, and Hirotoshi Kitagawa, and Kozo Ishino, and Shunji Sano, and Hidezo Mori
September 1997, International journal of dermatology,
Yosuke Kuroko, and Toji Yamazaki, and Noriyuki Tokunaga, and Tsuyoshi Akiyama, and Hirotoshi Kitagawa, and Kozo Ishino, and Shunji Sano, and Hidezo Mori
October 1982, Endocrinology,
Yosuke Kuroko, and Toji Yamazaki, and Noriyuki Tokunaga, and Tsuyoshi Akiyama, and Hirotoshi Kitagawa, and Kozo Ishino, and Shunji Sano, and Hidezo Mori
April 1992, Circulation,
Yosuke Kuroko, and Toji Yamazaki, and Noriyuki Tokunaga, and Tsuyoshi Akiyama, and Hirotoshi Kitagawa, and Kozo Ishino, and Shunji Sano, and Hidezo Mori
January 1985, Journal of cardiovascular pharmacology,
Yosuke Kuroko, and Toji Yamazaki, and Noriyuki Tokunaga, and Tsuyoshi Akiyama, and Hirotoshi Kitagawa, and Kozo Ishino, and Shunji Sano, and Hidezo Mori
June 1996, JAMA,
Yosuke Kuroko, and Toji Yamazaki, and Noriyuki Tokunaga, and Tsuyoshi Akiyama, and Hirotoshi Kitagawa, and Kozo Ishino, and Shunji Sano, and Hidezo Mori
May 1987, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society,
Yosuke Kuroko, and Toji Yamazaki, and Noriyuki Tokunaga, and Tsuyoshi Akiyama, and Hirotoshi Kitagawa, and Kozo Ishino, and Shunji Sano, and Hidezo Mori
January 1990, Basic research in cardiology,
Yosuke Kuroko, and Toji Yamazaki, and Noriyuki Tokunaga, and Tsuyoshi Akiyama, and Hirotoshi Kitagawa, and Kozo Ishino, and Shunji Sano, and Hidezo Mori
November 1983, World journal of surgery,
Copied contents to your clipboard!